BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25189320)

  • 1. Expression of TRAP1 predicts poor survival of malignant glioma patients.
    Li S; Lv Q; Sun H; Xue Y; Wang P; Liu L; Li Z; Li Z; Tian X; Liu YH
    J Mol Neurosci; 2015 Jan; 55(1):62-68. PubMed ID: 25189320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer.
    Lv Q; Sun H; Cao C; Gao B; Qi Y
    Tumour Biol; 2016 Feb; 37(2):2721-7. PubMed ID: 26408177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma.
    Tian L; Zhang Y; Chen Y; Cai M; Dong H; Xiong L
    PLoS One; 2013; 8(3):e58069. PubMed ID: 23516431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAP1 shows clinical significance and promotes cellular migration and invasion through STAT3/MMP2 pathway in human esophageal squamous cell cancer.
    Ou Y; Liu L; Xue L; Zhou W; Zhao Z; Xu B; Song Y; Zhan Q
    J Genet Genomics; 2014 Oct; 41(10):529-37. PubMed ID: 25438697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
    Pak MG; Koh HJ; Roh MS
    Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
    J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WTAP Expression Predicts Poor Prognosis in Malignant Glioma Patients.
    Xi Z; Xue Y; Zheng J; Liu X; Ma J; Liu Y
    J Mol Neurosci; 2016 Oct; 60(2):131-6. PubMed ID: 27370540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas.
    Wang L; Qin H; Li L; Zhang Y; Tu Y; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
    Med Oncol; 2012 Dec; 29(5):3491-7. PubMed ID: 22926920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.
    Tu Y; He S; Fu J; Li G; Xu R; Lu H; Deng J
    Clin Transl Oncol; 2012 Mar; 14(3):214-20. PubMed ID: 22374425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of STIP1 regulate apoptosis and invasion of glioma cells via TRAP1/AKT signaling pathway.
    Yin H; Deng Z; Li X; Li Y; Yin W; Zhao G; Jiang D; Sun C; Zhou Y
    Cancer Genet; 2019 Sep; 237():1-9. PubMed ID: 31447061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma.
    Yang Y; Zhang C; Li L; Gao Y; Luo X; Zhang Y; Liu W; Fei Z
    World J Surg Oncol; 2012 Aug; 10():169. PubMed ID: 22913315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis.
    Yang J; Liao D; Wang Z; Liu F; Wu G
    J Surg Res; 2011 Jun; 168(1):97-102. PubMed ID: 20036387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
    Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer.
    Zhang B; Wang J; Huang Z; Wei P; Liu Y; Hao J; Zhao L; Zhang F; Tu Y; Wei T
    Oncotarget; 2015 Dec; 6(42):44495-508. PubMed ID: 26517089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tumor necrosis factor receptor-associated protein 1 and its clinical significance in kidney cancer.
    Si T; Yang G; Qiu X; Luo Y; Liu B; Wang B
    Int J Clin Exp Pathol; 2015; 8(10):13090-5. PubMed ID: 26722505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of microRNA-134 correlates with malignancy and poor prognosis in human glioma.
    Zhong J; Li B
    J Clin Neurosci; 2015 Mar; 22(3):583-7. PubMed ID: 25564273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
    Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
    Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of microRNA-124 predicts poor prognosis in glioma patients.
    Chen T; Wang XY; Li C; Xu SJ
    Neurol Sci; 2015 Jan; 36(1):131-5. PubMed ID: 25112530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium.
    Aust S; Bachmayr-Heyda A; Pateisky P; Tong D; Darb-Esfahani S; Denkert C; Chekerov R; Sehouli J; Mahner S; Van Gorp T; Vergote I; Speiser P; Horvat R; Zeillinger R; Pils D
    Mol Cancer; 2012 Sep; 11():69. PubMed ID: 22978347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma.
    Kuchitsu Y; Nagashio R; Igawa S; Kusuhara S; Tsuchiya B; Ichinoe M; Satoh Y; Naoki K; Murakumo Y; Saegusa M; Sato Y
    Biomed Res; 2020; 41(1):53-65. PubMed ID: 32092740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.